Aft Pharmaceuticals Share Price and Company Fundamentals



Price
$3.9
Change
0.000 (0.000%)
52 week
3.64 - 5.25

Last traded: Last Thursday at 4:39 AM

AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Southeast Asia, and internationally. The company offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail and oral care, pain management, skin care, and other products, as well as supplements. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Key Metrics

PE ratio

54.29

PB ratio

11.70

Dividend yield

Beta

0.16

Market cap

$409.46M

Enterprise value

$446.68M

Company profile

Primary activitiesAFT is a growing multinational pharmaceutical business with a broad range of products, both developed itself and in-licensed from third parties. AFT¿¿¿¿¿¿¿¿¿¿¿¿s products cover all major pharmaceutical distribution channels: over-the-counter,
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Full time employees94
Websitehttp://www.aftpharm.com
Mailing address129 Hurstmere Road Level 1 Takapuna Auckland 0622 New Zealand
Phone / Fax64 9 488 0232 / 64 800 423 874
Share registryCOMPUTERSHARE INVESTOR SERVICES LIMITED

Dividends

Aft Pharmaceuticals does not pay dividends.

Company Executives

As of Oct 2021, following are the company executives and directors listed on Aft Pharmaceuticals.

NameTitleAgeTotal Pay
Dr. Hartley AtkinsonFounder, CEO, MD & Exec. Director504.9k
Ms. Marree AtkinsonChief of Staff & Exec. Director98.51k
Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZCFO & Company Sec.
Mr. Murray KeithGroup Marketing Mang.
Ms. Ioana StanescuHead of Drug Devel.
Mr. Calvin MackenzieGen. Mang. of AFT Australia
Mr. Scott CrawfordGen. Mang. of Promoted Products Australasia & South East Asia
Ms. Louise ClaytonDirector of International Bus.

Profitability and management effectiveness

Profit margin

6.88%

Operating margin

9.47%

Return on assets

6.97%

Return on equity

28.91%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Aft Pharmaceuticals is 409.46M and its enterprise value is 446.68M. The enterprise value to revenue ratio of AFP is 3.95.

The AFP's stocks Beta value is 0.16 making it 84% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Aft Pharmaceuticals (AFP)

Aft Pharmaceuticals (ASX:AFP) Frequently Asked Questions

1. What is Aft Pharmaceuticals's Stock Symbol?

Aft Pharmaceuticals trades on ASX under the ticker symbol "AFP".

2. What is Aft Pharmaceuticals's stock price today?

One share of AFP stock can currently be purchased for approximately $3.9.

3. How can I contact Aft Pharmaceuticals?

Aft Pharmaceuticals's mailing address is 129 Hurstmere Road Level 1 Takapuna Auckland 0622 New Zealand. The company can be reached via phone at 64 9 488 0232.

4. What is Aft Pharmaceuticals's official website?

The official website of Aft Pharmaceuticals is http://www.aftpharm.com.

5. Which share registry manages Aft Pharmaceuticals's stock?

Aft Pharmaceuticals's stock is managed by COMPUTERSHARE INVESTOR SERVICES LIMITED.